![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-01.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-02.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-03.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-04.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-05.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-06.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-07.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-08.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-09.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-10.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-11.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-12.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-13.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-14.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-15.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-16.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-17.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-18.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-19.jpg)
![RIVASTIGMINE PATCH [MYLAN PHARMACEUTICALS INC.]](https://medic.hrt.org//dailymed/images/5166/image-20.jpg)
| NDC | 0378-9070-16, 0378-9070-93, 0378-9071-16, 0378-9071-93, 0378-9072-16, 0378-9072-93 |
| Set ID | 4ab335d1-19ee-4cd9-9776-8086645d19e4 |
| Category | HUMAN PRESCRIPTION DRUG LABEL |
| Packager | Mylan Pharmaceuticals Inc. |
| Generic Name | |
| Product Class | |
| Product Number | |
| Application Number | ANDA205622 |